In NPH, altered CSF flow promotes the accumulation of neurotoxic metabolites, including amyloid beta (Aβ) and tau, which interfere with cellular function and accelerate neurodegenerative processes (Guzelcicek et al., 2021, Klemke et al., 2023). The gene discussed is MAPT; the disease is normal pressure hydrocephalus.